Does Nattokinase Clean Arteries? Reviewing the Evidence

Nattokinase does not mechanically "scrub" arteries, but clinical studies indicate it possesses significant fibrinolytic properties that can degrade arterial plaque. While not a literal pipe cleaner, nattokinase exhibits unique clot-busting properties distinguishing it from standard blood thinners.

Understanding the "Cleaning" Mechanism: Fibrinolysis

Fibrinolysis breaks down fibrin, a protein involved in blood clotting. In atherosclerosis, fibrin acts as scaffolding trapping cholesterol and calcium, stabilizing plaque deposits on artery walls.

Nattokinase dismantles this protein structure by removing the internal binding material, making clots less stable and more available for the body's natural clearance mechanisms.

Difference Between Blood Thinning and Plaque Reduction

Anticoagulants reduce blood viscosity without shrinking existing atherosclerosis. Nattokinase is unique because recent studies suggest it may actually shrink existing plaque burden—a distinction with significant clinical implications.

What Recent Studies Reveal About Plaque Volume

Recent clinical trials cite up to 36% plaque size reduction in the carotid artery. High-dose protocols often exceed standard 2,000 FU retail doses, with results appearing after 6–12 months of sustained use.

Mechanism of Action: How Nattokinase Works in the Body

Breaking Down Cross-Linked Fibrin

Nattokinase resembles plasmin, the enzyme the body naturally produces to dissolve clots. It stimulates tissue plasminogen activator (t-PA) production, creating dual therapeutic effects.

Impact on Lipid Profiles and Cholesterol

Studies show modest reductions in LDL cholesterol and triglycerides alongside fibrin degradation. The enzyme prevents fat oxidation, reducing inflammatory arterial responses.

Reduction of Blood Viscosity and Pressure

Nattokinase improves blood rheology—the physics of how blood flows—and exhibits mild ACE-inhibitor-like effects, relaxing blood vessels and lowering systemic blood pressure.

Anti-Inflammatory Effects on Blood Vessels

Atherosclerosis is fundamentally an inflammatory disease. Nattokinase lowers C-reactive protein markers in clinical settings, suggesting systemic anti-inflammatory activity beyond its fibrinolytic mechanism.

Nattokinase vs. Standard Heart Treatments

Treatment	Mechanism	Primary Effect	Main Risk
Nattokinase	Dissolves fibrin directly	Plaque regression & flow	Bleeding (dose-dependent)
Statins	Inhibits liver cholesterol	Plaque stabilization	Muscle pain / Liver stress
Aspirin	Inhibits platelet sticking	Clot prevention	Gastric bleeding / Ulcers

Nattokinase vs. Statins

Statins prevent cholesterol production while nattokinase actively degrades fibrin mesh within plaque. These agents target different mechanisms and may work complementarily.

You should never stop prescribed statins in favor of nattokinase without strict physician oversight. These are not interchangeable treatments.

Nattokinase vs. Aspirin

Aspirin makes blood cells slippery, preventing clumping. Nattokinase dissolves the protein web binding clots. Combining both creates additive bleeding risks that require medical supervision.

Reviewing the Evidence: Clinical Studies on Atherosclerosis

The 36% Plaque Reduction Study

A landmark study administered high-dose nattokinase (6,000–10,800 FU daily) to hyperlipidemia patients. After 26 weeks, researchers observed approximately 36% carotid plaque reduction in the high-dose group.

Impact on Carotid Artery Intima-Media Thickness

CCA-IMT measures inner carotid artery lining thickness, serving as a gold-standard atherosclerosis marker. Nattokinase supplementation measurably decreased this measurement in trial participants.

Synergy with Vitamin K2

Many protocols combine nattokinase with Vitamin K2 (MK-7) to optimize calcium handling. However, major plaque reduction studies isolate nattokinase as the primary variable, making the synergy hypothesis plausible but not definitively proven.

Limitations of Current Research

Many studies have relatively small sample sizes compared to major pharmaceutical trials. Many were conducted in Asian populations potentially differing from Western dietary baselines. Nattokinase remains non-standard in Western cardiology despite promising results.

Safety Profile and When to Avoid Nattokinase

Bleeding Risks and Blood Thinner Interactions

The most significant risk is excessive bleeding. Nattokinase powerfully interacts with Warfarin, Heparin, and newer anticoagulants like Eliquis, potentially causing dangerous internal hemorrhage.

Monitor for unusual bleeding signs including frequent nosebleeds, severe bruising, or dark tarry stools.

Surgery and Dental Procedures

Discontinue nattokinase at least two weeks before scheduled surgery or major dental work. Always inform healthcare providers about fibrinolytic enzyme use.

Contraindications for Specific Conditions

Avoid nattokinase with active bleeding ulcers, hemorrhagic stroke history, or bleeding disorders like hemophilia. Safety data for pregnancy and breastfeeding remains insufficient.

How to Take Nattokinase for Maximum Efficacy

Understanding Fibrinolytic Units (FU)

Dosage measures in Fibrinolytic Units indicating enzyme activity level. Standard retail supplements offer 2,000 FU per capsule, though plaque reduction studies utilized 6,000–10,000 FU daily doses.

Timing and the Empty Stomach Requirement

For the enzyme to reach the bloodstream, it must be taken on an empty stomach. Take one hour before food or two hours after meals. Taking with food causes the enzyme to digest meal proteins rather than targeting arterial fibrin.

Enteric Coating Importance

Stomach acid can denature enzymes before small intestine absorption. Prioritize acid-resistant formulations that maximize bioavailability and enzyme activity.

How Long to See Results

Nattokinase is not a quick fix—it works gradually over time. Clinical trials tracked participants 26–52 weeks before confirming significant structural changes. Consistency maintains therapeutic enzyme blood levels.

FAQ

Does nattokinase dissolve calcified plaque?

Nattokinase primarily targets fibrin and soft plaque. It doesn't directly dissolve calcium deposits but may destabilize the fibrin mesh holding calcifications in place.

Can I eat natto food instead of taking supplements?

Fermented soybeans provide natural nattokinase, though dosage varies widely, making consistent high clinical trial doses difficult through food alone.

Is nattokinase safe to take daily?

For healthy adults without bleeding disorders, daily use is generally considered safe at standard doses. Long-term safety at extremely high doses (10,000+ FU) remains less established.

Can nattokinase cause blood clots to move?

Nattokinase dissolves clots by breaking them down chemically rather than dislodging them. Anyone with deep vein thrombosis should consult doctors before use.

Conclusion

The evidence for nattokinase as a cardiovascular support supplement is promising but not yet conclusive by the standards of major pharmaceutical trials. Its fibrinolytic mechanism is well-characterized, and plaque reduction studies are encouraging. Used appropriately and with medical oversight, it represents a compelling addition to evidence-based longevity protocols.